ufﬁciency also increases
the risk of stroke after CEA (1.08%-5.56%). Among asymptomatic patients with cardiac or renal insufﬁciency, best

medical therapy may be preferable to transfemoral
CAS or CEA. CEA or transfemoral CAS may be considered
among symptomatic high-risk patients with moderate
to severe carotid stenosis, but the effectiveness over
medical therapy is not well-established.
There are con